Dr. Barry Wessels to Speak At the Winter Institute of Medical Physics Conference
(Business Wire)...~~~ Dr. Wessels has played a major role in analyzing and interpreting data generated from Peregrine`s brain cancer trials using the radiolabeled Tumor Necrosis Therapy monoclonal antibody named Cotara(TM).......rather than surface cancer cells, as a means to attack solid tumors, without causing damage to surrounding healthy tissue....- Feb 14 7:34 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010214/ca_peregri.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines